Exonucleolytic degradation of RNA by p53 protein in cytoplasm.
p53 in cytoplasm displays an intrinsic 3'-->5' exonuclease activity. To understand the significance of p53 exonuclease activity in cytoplasm, cytoplasmic extracts of various cell lines were examined for exonuclease activity with different single-stranded RNA (ssRNA) substrates. Using an in vitro RNA degradation assay, we observed in cytoplasmic extracts of LCC2 cells, expressing high levels of endogenous wtp53, an efficient 3'-->5' exonuclease activity with RNA substrates, removing the 3'-terminal nucleotides. Interestingly, RNA containing AU-rich sequences (ARE) is the permissive substrate for exonucleolytic degradation. Evidence that exonuclease function with RNA detected in cytoplasmic extracts is attributed to the p53 is supported by several facts: (1) this activity closely parallels with status and levels of endogenous cytoplasmic p53; (2) the endogenous exonuclease exerts identical RNA substrate specificity and excision profile characteristic for purified baculovirus-or bacterially-expressed wtp53s; (3) the exonuclease activity with ARE RNA is competed out by the presence of ss or double-stranded DNA substrate utilized by p53 protein in cytoplasm; (4) immunoprecipitation by specific anti-p53 antibodies markedly reduced the exonuclease activity with both RNA and DNA substrates; and (5) transfection of the wtp53, but not exonuclease-deficient mutant p53-R175H, into p53-null H1299 or HCT116 cells induced high levels of exonuclease activity with ARE RNA substrate in cytoplasm with characteristic excision profile. The efficient ARE RNA degradation correlates with the efficient binding of p53 to ARE RNA in cytoplasm. The possible role of p53 exonuclease activity in ARE-mRNA destabilization in cytoplasm, which may be important for expression of proteins that control cell growth and/or apoptosis is discussed.
Bakhanashvili
Mary
M
Infectious Diseases Unit, Sheba Medical Center, Tel Hashomer, Israel. bakhanus@yahoo.com
Gedelovich
Rachel
R
Grinberg
Shai
S
Rahav
Galia
G
D001483:Base Sequence; D003593:Cytoplasm / Q000737:chemistry; D005092:Exonucleases / Q000378:metabolism*; D006801:Humans; D012313:RNA / Q000378:metabolism*; D020871:RNA Stability; D013379:Substrate Specificity; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D016159:Tumor Suppressor Protein p53; D012313:RNA; D005092:Exonucleases
EMBO J. 1995 Sep 15;14(18):4442-9
7556087
EMBO J. 2001 Feb 15;20(4):914-23
11179235
Oncogene. 2000 Aug 17;19(35):4042-9
10962561
EMBO J. 1993 Jun;12(6):2389-96
7685274
Oncogene. 2001 Nov 15;20(52):7635-44
11753641
Growth Factors. 1996;13(1-2):99-110
8804994
Oncogene. 2004 Sep 9;23(41):6890-9
15286711
Eur J Biochem. 2001 Apr;268(7):2047-54
11277927
J Biol Chem. 2002 Dec 13;277(50):48558-64
12324455
Biochemistry. 1992 Oct 6;31(39):9393-8
1382590
Oncogene. 1998 Jul 23;17(3):261-70
9690508
FEBS Lett. 1999 May 7;450(3):197-204
10359074
Nature. 1992 Jul 2;358(6381):15-6
1614522
Oncogene. 2004 May 27;23(25):4371-9
15064727
Oncogene. 2003 Jun 5;22(23):3554-61
12789264
J Biol Chem. 2000 May 26;275(21):16202-12
10821866
Oncogene. 2003 Jan 16;22(2):233-45
12527892
Int J Radiat Biol. 1998 Dec;74(6):729-37
9881718
EMBO J. 2002 Jan 15;21(1-2):165-74
11782436
Biochem Soc Trans. 2002 Nov;30(Pt 6):952-8
12440953
Nucleic Acids Res. 1991 May 11;19(9):2499
2041787
J Biol Chem. 2005 Jun 10;280(23):22406-17
15809297
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):424-8
9892649
Nucleic Acids Res. 2002 Apr 1;30(7):1493-9
11917009
Oncogene. 2000 Jul 6;19(29):3321-9
10918588
Mol Cell Biol. 2000 Nov;20(22):8420-31
11046139
Mol Cell Biol. 1994 Nov;14 (11):7414-20
7935455
Trends Biochem Sci. 1995 Nov;20(11):465-70
8578590
Antimicrob Agents Chemother. 2005 Apr;49(4):1576-9
15793143
Oncogene. 1993 May;8(5):1183-93
8479742
Mol Cell Biol. 1995 Apr;15(4):2219-30
7891716
Cancer Invest. 2002;20(4):509-17
12094546
J Pathol. 1999 Jan;187(1):112-26
10341712
Oncogene. 1994 Jul;9(7):1925-9
8208539
Cell. 1996 Jun 28;85(7):1089-99
8674115
Oncogene. 1999 Dec 13;18(53):7706-17
10618711
Mol Cell Biol. 1992 Nov;12(11):5145-51
1406686
Mol Cell Biol. 1996 Apr;16(4):1490-9
8657122